|
Re: Pfizer
|
5
|
Zenith Epigenetics
|
Jun 03, 2020 12:27PM
|
|
Re: Zenith Capital Corporation symbol
|
5
|
Zenith Epigenetics
|
May 20, 2020 08:01PM
|
|
Canadian government support for business
|
4
|
Resverlogix Corp.
|
May 11, 2020 03:10PM
|
|
Re: Zenith News
|
3
|
Zenith Epigenetics
|
May 04, 2020 05:46PM
|
|
Re: https://scr.zacks.co...
|
5
|
Zenith Epigenetics
|
May 04, 2020 11:22AM
|
|
Re: Is this bad for RVX but right, on the money?
|
8
|
Resverlogix Corp.
|
Apr 25, 2020 07:58AM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
1
|
Zenith Epigenetics
|
Apr 19, 2020 07:35PM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
1
|
Zenith Epigenetics
|
Apr 18, 2020 10:00AM
|
|
Re: Shawn lu RSU and option cancelled
|
6
|
Resverlogix Corp.
|
Apr 05, 2020 10:02AM
|
|
Shawn lu RSU and option cancelled
|
6
|
Resverlogix Corp.
|
Apr 05, 2020 09:12AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Mar 31, 2020 05:43PM
|
|
Amarin Patent issue and Litigation
|
6
|
Resverlogix Corp.
|
Mar 31, 2020 10:03AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 30, 2020 07:20PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 30, 2020 12:15PM
|
|
Re: This Covid 19 possibility has
|
7
|
Resverlogix Corp.
|
Mar 26, 2020 10:17AM
|
|
Angiotensin and Coronavirus
|
5
|
Resverlogix Corp.
|
Mar 23, 2020 05:49PM
|
|
Re: Epigenetics and Coronavirus
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 04:57PM
|
|
Re: Epigenetics and Coronavirus
|
6
|
Resverlogix Corp.
|
Mar 23, 2020 10:42AM
|
|
Epigenetics and Coronavirus
|
2
|
Resverlogix Corp.
|
Mar 22, 2020 08:21PM
|
|
Re: BRD2 involvement in Covid19
|
4
|
Resverlogix Corp.
|
Mar 18, 2020 03:30PM
|
